AI that predicts progress of Alzheimer's disease

Health, News.

Scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.

This new approach could reduce the need for invasive and costly diagnostic tests while improving treatment outcomes early when interventions such as lifestyle changes or new medicines may have a chance to work best.

The machine learning model is able to predict whether and how fast an individual with mild memory and thinking problems will progress to developing Alzheimer’s disease. It is more accurate than current clinical diagnostic tools.

The model also allowed the researchers to stratify people with Alzheimer’s disease using data from each person’s first visit at the memory clinic into three groups: those whose symptoms would remain stable, those who would progress to Alzheimer’s slowly and those who would progress more rapidly.

YOU MAY ALSO LIKE

Wrecking Cellular Recycling to Learn About Lung Cancer

You’ve probably heard all about the importance of recycling paper and plastic, but did you know that your cells have a recycling process too?

Improving Disparities in Diabetes Detection

Our bodies use the hormone insulin to control our blood sugar levels, and when cells resist insulin’s effects, it can lead to diabetes. Unfortunately, many of the common tests used to detect insulin resistance are less accurate in people from certain racial and ethnic groups.

Using Neuroscience to Reverse Obesity

Maintaining a healthy body weight is difficult for many people, and consuming different sorts of foods might make it easier or harder to accomplish that goal.

Alcohol and Your Brain

Take a rollercoaster ride through the brain to learn about alcohol’s harmful effects on five different brain structures.

Turning a Deadly Toxin Into a Cancer Killer

Most people think of the anthrax toxin only as a potential bioweapon

The Relationship Between Sleep, Circadian Rhythms, and Opioid Use Disorder

Dr. Ryan Logan from the University of Massachusetts talks about his research in both humans and animal models.